Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Achillion Pharmaceuticals, Inc. (NQ: ACHN)
7.740 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 8:10 PM EDT, May 22, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Achillion Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Achillion to Present at the Noble Financial Capital Markets' Ninth Annual Equity Conference
January 17, 2013
from GlobeNewswire News Releases
8 Biotechnology Stocks to Sell Now
January 16, 2013
 Read More
category NASDAQ:FOLD , NYSE:ELN , NASDAQ:ACHN , and 6 more.
from InvestorPlace - Latest Headlines
Record Levels of Available Cash and Moderate R&D Development Will See Big Pharma M&A Activity Increase in 2013
January 09, 2013
Five Star Equities Provides Stock Research on Achillion Pharmaceuticals and Dendreon Read More
from Marketwired News Releases
Four Laggards (ESI, SPWR, LDK, ACHN)
January 08, 2013
Los Angelas, CA -- (SBWIRE) -- 01/08/2013 -- HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks.... Read More
from SBWire - Latest Press Releases
Free Research Reports on ACHN, CHTP, NSM and SQNM Issued by the Bedford Report
January 08, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Mid-Day Market Update: SolarCity Wins Big, SunPower Continues its Fall
January 07, 2013
Following the market opening Monday, the Dow traded down 0.59 percent to 13,355.80 while the NASDAQ fell 0.38 percent to 3,089.47. The S&P also fell, decreasing 0.61 percent to 1,457.25. Top Headline... Read More
category Earnings , Benzinga , Movers , and 23 more.
from Latest Articles from Benzinga.com
Morning Market Losers
January 07, 2013
ITT Educational Services (NYSE: ESI ) shares dipped 19.49% to $15.53 at 9:54 am. ITT Educational Services agreed to pay $46 million to Sallie Mae to settle loan dispute. Innsuites Hospitality Trust... Read More
category Morning Market Losers , Benzinga , News , and 9 more.
from Latest Articles from Benzinga.com
Achillion Pharma (ACHN) Completes Enrollment in ACH-3102 Phase 2a; No Adverse Effects Reported
January 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7988869 for the full story. Read More
from StreetInsider.com News Articles
Achillion Reports Interim Results on ACH-3102
January 07, 2013
from GlobeNewswire News Releases
Baird Starts Achillion Pharmaceuticals (ACHN) at Outperform
January 03, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7983255 for the full story. Read More
from StreetInsider.com News Articles
Bank of America Merrill Lynch Reiterates Buy Rating, $13 PT on Achillion Pharmaceuticals
December 26, 2012
In a report published Wednesday, Bank of America Merrill Lynch reiterated its Buy rating and $13.00 price target on Achillion Pharmaceuticals (NASDAQ: ACHN ). BofA Merrill Lynch noted, “In early... Read More
category Reiteration , US00448Q2012 , Benzinga , and 4 more.
from Latest Articles from Benzinga.com
Achillion Pharmaceuticals Inc. is Now Oversold (ACHN)
December 03, 2012
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... Read More
category Stocks
from Market News Video
Achillion to Present at Two Upcoming Investor Conferences
November 30, 2012
from GlobeNewswire News Releases
Lessons from the Liver Meeting: Sagient’s John Tucker Names Companies That Could Reignite the Hepatitis C Industry
November 30, 2012
category Pharmaceuticals
from Trefis
Achillion to Present at Two Upcoming Investor Conferences
November 13, 2012
from GlobeNewswire News Releases
Direction Change Ahead, What to Expect - Research & Analysis on Achillion Pharmaceuticals, Inc. and Vertex Pharmaceuticals Incorporated
November 13, 2012
from Marketwired News Releases
Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry's Success in 2012
November 13, 2012
Five Star Equities Provides Stock Research on Achillion Pharmaceuticals and Sequenom Read More
from Marketwired News Releases
Stocks at New Highs, New Lows for 11/13
November 13, 2012
 Read More
category NASDAQ:IDIX , NASDAQ:GILD , NYSE:MCP , and 2 more.
from InvestorPlace - Latest Headlines
Flat Close Over Economic Concerns
November 12, 2012
Global economic concerns weighed the markets down to a flat close the Dow holding steady at 12,815. Nasdaq held steady at 2904. Read More
category Market News
from MarketMinute.com Market Updates
Streetinsider.com's Hot Lunchtime Reads 11/12: (BE) (SRPT) (CKEC) (FB) (ACHN)
November 12, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7866328 for the full story. Read More
from StreetInsider.com News Articles
Achillion Pharmaceuticals (ACHN) Weakness is a Buying Chance - Analyst
November 12, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7866298 for the full story. Read More
from StreetInsider.com News Articles
NASDAQ Gain Momentum on News (CLVS, STSI, ACHN, MYRX, SRPT)
November 12, 2012
New York, NY -- (SBWIRE) -- 11/12/2012 -- TooNiceStocks-Sign up for weekly Technical and Equity Research Reports covering all equity sectors. We have a proven track record, please come visit and see... Read More
from SBWire - Latest Press Releases
Gilead Among Healthcare's Biggest Movers on November 12, 2012
November 12, 2012
The Nasdaq has decreased 0.1%, the S&P 500 has moved little and the Dow is trading down 0.1% so far today. The healthcare sector is the category of stocks relating to medical and healthcare goods or s... Read More
from Investopedia Advisor Commentary
Gilead and Other Big Movers on the Nasdaq on November 12, 2012
November 12, 2012
Currently, the Nasdaq has declined 0.1%, the S&P 500 is unchanged and the Dow has slipped 0.1%. The recent surge in popularity of technological stocks has launched the Nasdaq Composite Index into the... Read More
from Investopedia Advisor Commentary
Achillion (ACHN) Updates on Sovaprevir, ACH-3102; Announces New Results frm ACH-2684
November 12, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7865073 for the full story. Read More
from StreetInsider.com News Articles
Achillion Provides Update on Clinical HCV Development Programs
November 12, 2012
from GlobeNewswire News Releases
Achillion Pharmaceuticals, Inc. Hosts the HCV Connection Media Briefing at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
November 09, 2012
from PR Newswire
Achillion Pharmaceuticals (ACHN) files a $200 million mixed securities shelf
November 08, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7859727 for the full story. Read More
from StreetInsider.com News Articles
Achillion Pharma (ACHN) Posts Q3 Loss of 20c/Share
November 08, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7855895 for the full story. Read More
from StreetInsider.com News Articles
Achillion Reports Third Quarter and Nine Month 2012 Financial Results
November 08, 2012
from GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here